BlackRock Institutional Trust’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $3.36M | Sell |
648,053
-3,180
| -0.5% | -$16.5K | ﹤0.01% | 2865 |
|
|
2016
Q3 | $3.63M | Buy |
651,233
+26,236
| +4% | +$146K | ﹤0.01% | 2818 |
|
|
2016
Q2 | $3.47M | Buy |
624,997
+37,434
| +6% | +$208K | ﹤0.01% | 2831 |
|
|
2016
Q1 | $2.59M | Sell |
587,563
-3,000
| -0.5% | -$13.2K | ﹤0.01% | 2929 |
|
|
2015
Q4 | $3.56M | Buy |
590,563
+84,638
| +17% | +$509K | ﹤0.01% | 2874 |
|
|
2015
Q3 | $3.96M | Buy |
505,925
+82,718
| +20% | +$647K | ﹤0.01% | 2825 |
|
|
2015
Q2 | $2.59M | Buy |
423,207
+106,768
| +34% | +$654K | ﹤0.01% | 3010 |
|
|
2015
Q1 | $2.55M | Buy |
316,439
+33,900
| +12% | +$273K | ﹤0.01% | 2997 |
|
|
2014
Q4 | $1.43M | Buy |
282,539
+11,274
| +4% | +$57.1K | ﹤0.01% | 3242 |
|
|
2014
Q3 | $1.41M | Buy |
271,265
+24,818
| +10% | +$129K | ﹤0.01% | 3203 |
|
|
2014
Q2 | $1.92M | Buy |
246,447
+19,052
| +8% | +$148K | ﹤0.01% | 3198 |
|
|
2014
Q1 | $1.59M | Buy |
227,395
+50,376
| +28% | +$352K | ﹤0.01% | 3258 |
|
|
2013
Q4 | $1.06M | Buy |
177,019
+77,764
| +78% | +$466K | ﹤0.01% | 3376 |
|
|
2013
Q3 | $774K | Buy |
99,255
+2,658
| +3% | +$20.7K | ﹤0.01% | 3432 |
|
|
2013
Q2 | $367K | Buy |
+96,597
| New | +$367K | ﹤0.01% | 3547 |
|